Searched for
EMERGENT BIOSOLUTIONS
Mukul Agarwal’s Sanshi Fund-backed Neochem Bio Solutions SME IPO opens. Check subscription status and other detailsNeochem Bio Solutions’ Rs 44.97 crore SME IPO opened on December 2 with a slow start, recording just 0.02 times subscription by mid-morning...- China’s India headache: The growing pharmaceutical industryIndian CDMOs are strategically expanding through acquisitions in the US and Europe, driven by global pharma's nearshoring trend and a desir...
- Syngene International shares in focus on acquiring first US biologics facility for $36.5 millionSyngene International announced acquiring its first biologics facility in the U.S. from Emergent Manufacturing for $36.5 million. This acqu...
- India's Syngene International acquires first US biologics facility for $36.5 millionIndia's Syngene International has agreed to acquire its first biologics facility in the U.S. from Emergent Manufacturing for $36.5 million....
- Mpox outbreak: Rich nations have millions of shots as Africa's outbreak spreads; will they share?Rich countries have hundreds of millions of vaccine doses that could help combat an mpox outbreak in Africa, where donated shots are insuff...
- Mpox-linked stocks extend rally into second week, Geo Vax up 47%Shares of some mpox vaccine and drug developers jumped sharply on Monday in premarket trading, putting them on track to extend gains from l...
- Monkeypox outbreak may boost the shares of these companies“At the moment, the world is relying on one manufacturer, Bavarian Nordic, for the monkeypox vaccine,” said Manish Bhargava, a fund manager...
- Study reveals hyperimmune intravenous immunoglobulin doesn't help COVID-19 patientsThe combination of remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2 is not more effective than remde...
- Emmanuel Macron announces 30-billion-euro plan to re-industrialise FranceFrench officials believe that France needs to act rapidly to close the gap and not surrender more ground to emerging powers, notably China.
- South Africa suspends 2 million Johnson & Johnson dosesFollowing a review of the FDA decision, the South African Health Products Regulatory Authority (SAHPRA) said in a statement that it had dec...
- US puts J&J in charge of plant that botched Covid vax, removes AstraZenecaJohnson & Johnson, with help from the Biden administration, is taking over a Baltimore vaccine production facility that was the site of a m...
- 15 million doses discarded: The company at the heart of J&J vaccine row had history of violationsJ&J locked arms with Emergent in April 2020, enlisting the lesser-known company to manufacture its vaccine. At the time, Emergent's Bayview...
- Johnson & Johnson COVID-19 vaccine batch fails quality checkA vaccine ingredient made by Emergent BioSolutions -- one of about 10 companies that Johnson and Johnson is using to speed up manufacturing...
- EU seeks new COVID-19 vaccine deal with Moderna, AstraZeneca flags doses made outside EU- SourcesThe European Union has set a target of vaccinating 70% of its adult population by the end of the summer, but has struggled to secure the do...
- Johnson & Johnson expects nod for Covid vaccine by early 2021: Paul Stoffels, chief scientific officer, J&JScientists and drug companies across the world are accelerating various treatments and vaccine options to tackle Covid-19, which has claime...
- Debt pile-up post Arysta Life buy may make UPL investors waryUPL signed a definitive agreement to acquire Arysta Life Science for $4.2 billion in an all cash consideration last Friday.
- Axio Biosolutions raises $7.4 million from Ratan Tata, othersThe first-aid dressing done with help of Axiostat stops uncontrollable bleeding within just 2-3 minutes of its application, thus saving liv...
- Axio raises Rs 47 crore from RNT Capital and othersThe round also gave an exit with 7X returns to the company’s first institutional investor, GVFL, an Ahmedabad-based venture capital firm.
- Medical devices startup Axio sets up plant, targets new verticalsFunded by Accel Partners, IDG Ventures and GVFL, the production unit in Ahmedabad will have installed capacity of 2.5 lakh units per year w...
- New antibody weapons against Marburg virus foundThe new antibodies identify and neutralise Marburg virus which has a mortality rate of up to 90 per cent.
Load More
